Skip to content

Jazz Pharmaceuticals

US · JAZZ #1123 by market cap Listed 1970
230.26 -6.19 -2.62%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
  • Total institutional ownership fell 1.2 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
102.93% -1.21pp
Institutions
815 -4
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund84.19%
Hedge Fund10.70%
Individual/Insider2.95%
Public Company2.57%
Government Pension Fund1.65%
Private Company1.05%
Sovereign Wealth Fund1.05%
VC/PE Fund0.89%
Insurance Company0.41%

Top holders as of 2026-09-30

BlackRock 10.06% · 6.45M sh
FMR 8.57% · 5.50M sh
Vanguard Capital Management, LLC 5.01% · 3.21M sh
Vanguard Portfolio Management, LLC 4.79% · 3.07M sh
Capital Research 3.73% · 2.39M sh
LSV Asset Management 3.33% · 2.14M sh
State Street Global Advisors 3.22% · 2.07M sh
Franklin Resources 3.03% · 1.94M sh
Geode Capital Management, LLC 2.39% · 1.53M sh
Fuller & Thaler Asset Management, Inc. 2.55% · 1.64M sh
Dimensional Fund Advisors 2.26% · 1.45M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 12 buys · 38 sells

NameRoleStake
Seamus Mulligan Independent Director 2.00%
Bruce Cozadd Chairperson 0.50%
Renee Gala Chief Executive Officer 0.08%
Kenneth O’Keefe Former Independent Director 0.04%
Robert Iannone Executive VP, Chief Medical Officer and Global Head of Research & Development 0.04%
Philip Johnson Chief Financial Officer 0.04%
Samantha Pearce Executive Vice President 0.03%
Neena Patil Chief Legal Officer 0.03%
Patrick Gerald Enright Independent Director 0.03%
Heather McSharry Independent Director 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-05 Bruce Cozadd Chairperson Derivative Exercise and Sale -68,808 $136.18–237.39
2026-11-05 Bruce Cozadd Chairperson Derivative Exercise and Retained +17,692 $136.18
2026-11-03 Patricia Carr Chief Accounting Officer Open Market Disposition -163 $231.27
2026-11-03 Patricia Carr Chief Accounting Officer Derivative Exercise and Sale -1,250 $140.03–231.37
2026-11-02 Renee Gala Chief Executive Officer Automatic Disposition -1,000 $225.37
2026-11-01 Bruce Cozadd Chairperson Automatic Disposition -6,000 $215.84
2026-10-07 Anne O'Riordan Former Independent Director Intent to Sell (Form 144) -14,687 $228.55
2026-10-05 Renee Gala Chief Executive Officer Automatic Disposition -2,000 $236.40
2026-09-30 Bruce Cozadd Chairperson Automatic Disposition -6,000 $230.33
2026-09-09 Neena Patil Chief Legal Officer Automatic Disposition -1,200 $240.94
2026-09-07 Renee Gala Chief Executive Officer Sale to Issuer -1,967 $246.81
2026-09-07 Renee Gala Chief Executive Officer Automatic Disposition -2,000 $243.03
2026-09-07 Mary Henderson Senior Vice President of Technical Operations Sale to Issuer -1,427 $241.20–243.03
2026-08-31 Bruce Cozadd Chairperson Automatic Disposition -6,000 $250.13
2026-08-30 Bruce Cozadd Chairperson Sale to Issuer -1,219 $241.39–244.06
2026-08-30 Norbert Riedel Independent Director Sale to Issuer -1,706 $241.39–244.64
2026-08-30 Ted Love Independent Director Sale to Issuer -743 $241.39–244.06
2026-08-30 Patrick Gerald Enright Independent Director Sale to Issuer -1,706 $241.39–244.64
2026-08-30 Patrick Kennedy Independent Director Sale to Issuer -1,855 $241.39–244.06
2026-08-30 Rick Winningham Lead Independent Director Sale to Issuer -1,706 $241.39–244.64

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:26 · For reference only, not investment advice and not tailored to your situation.

Jazz Pharmaceuticals discussion 0 comments

Add a comment